Pfizer was making on average $50b revenue [1] before COVID.
And the profits they generated by COVID could well save countless more lives given that their MRNA technology is successfully being applied to other use cases.
[1] https://www.macrotrends.net/stocks/charts/PFE/pfizer/revenue